Rodolfo Gasser,Maria-Clemencia Hernandez,Andrew Thomas
申请号：
US13286240
公开号：
US20120115839A1
申请日:
2011.11.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to the pharmaceutical use of selective GABA A α5 negative allosteric modulators for the treatment, prevention and/or delay of progression of central nervous system (CNS) conditions related to excessive GABAergic inhibition in the brain.
